Clinical trial Recruiting at 1 site Observational Ages 40 to 70

Screening blood biomarkers for osteoarthritis diagnosis

Official title: Screening of Biomarkers for Osteoarthritis and Establishment of a Multidimensional Data Based Early Diagnostic Method

Run by The First Affiliated Hospital of Xinxiang Medical College · NCT07544823 · Data updated 2026-11-12

This project will test whether certain blood biomarkers can help diagnose osteoarthritis in people aged 40–70 who have had joint pain or stiffness for at least three months.

Quick facts

Study typeObservational
Ages40 Years to 70 Years
SexAll
Enrollment300 (estimated)
SponsorThe First Affiliated Hospital of Xinxiang Medical College
Academic / other
Locations1 site (Xinxiang, Henan)
StatusRecruiting
StartedApril 20, 2026
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedApril 22, 2026
Trial IDNCT07544823 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40–70 with joint pain or stiffness lasting at least three months who can give informed consent and complete imaging, blood draws, and follow-up visits are ideal candidates.

Probably not a fit

Patients with other severe joint diseases (such as rheumatoid arthritis or gout), recent joint surgery, severe systemic illness, cognitive impairment, or inability to complete required imaging or follow-up are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will collect blood samples from patients with diagnosed or suspected osteoarthritis attending the orthopedic outpatient department of a tertiary hospital in Xinxiang. Diagnostic and differential tests, including X-ray and MRI, will be used alongside laboratory analysis to compare previously reported candidate biomarkers with clinical diagnoses. The goal is to identify biomarkers that show reliable validity and reproducibility for early detection or differentiation of OA. Participants must meet inclusion/exclusion criteria and complete required imaging and follow-up visits.

Why it matters

Potential benefit: If successful, validated blood biomarkers could enable earlier and more accurate diagnosis of osteoarthritis, potentially reducing delayed treatment and long-term disability.

How similar studies have gone: Some candidate OA biomarkers have been reported in prior research, but none have been universally validated for routine clinical use, so this project builds on preliminary findings rather than testing an already proven diagnostic.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged between 40 and 70 years (inclusive);
2. Joint pain or stiffness lasting for no less than 3 months;
3. Voluntary participation with signed informed consent.

Exclusion Criteria:

1. Combined with other severe joint diseases, such as rheumatoid arthritis, gout, etc.;
2. Suffering from severe systemic diseases, such as heart failure, malignant tumors and others;
3. Received joint surgery within the past 3 months or taking medications that may affect the progression of osteoarthritis;
4. Individuals with cognitive dysfunction who are unable to cooperate with the research procedures;
5. Failure to complete X-ray, MRI examination or follow-up visits as required.

Where it's running

  • The First Affiliated Hospital of Henan Medical University
    Xinxiang, Henan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.